Analysis of the Risk Factors and Clinical Outcomes of Femoral Intertrochanteric Fractures in Patients over 65 Years Old.
- Author:
Chul Hong KIM
1
;
Kyu Yeol LEE
;
Sung Soo KIM
;
Myung Jin LEE
;
Lih WANG
;
Hyeon Jun KIM
;
Jung Mo KANG
Author Information
- Publication Type:Original Article
- Keywords: Intertrochanteric fracture; Mortality
- MeSH: Anesthesia; Cardiovascular Diseases; Drinking; Femoral Fractures; Hip Fractures; Humans; Perioperative Care; Postoperative Complications; Risk Factors; Smoke; Smoking
- From:Hip & Pelvis 2013;25(2):127-134
- CountryRepublic of Korea
- Language:Korean
- Abstract: PURPOSE: This study examined therelationship between the clinical outcome and risk factors of intertrochanteric femoral fractures in patients over 65 years old. MATERIALS AND METHODS: From January 2000 to March 2012, three hundred and twenty one patients older than 65 years, who underwent surgeryfor intertrochanteric femoral fractures, were evaluated. The following parameters wereanalyzed: the patient risk factors, such as age, sex, smoking, drinking history, cardiovascular disease, cerebrovascular disease and delayed days to surgery; admission day of the week; anesthetic method; operation time by perioperative care related to clinical outcome including postoperative mortality; and complications. RESULTS: An analysis of the risk factors revealedfemale patients to have a 13% higher mortality (P=0.043). Aduration of surgerylonger than 3 hours was associated with a 29.1% and 20.8% higher mortality and complication rate, respectively (P<0.001, P=0.027). Asurgical delay of four days or more after admission wasassociated with a 20.1% and 18.8% higher mortality risk and complication rate, respectively (P<0.001, P<0.001). Smoking, drinking history, underlying disease, anesthetic method, and operation time had no significant effect on the outcome. CONCLUSION: In addition to recognizing the importance of patient-related risk factors, modifying the operative factors, such as reducing surgical delays and method of anesthesia, can reduce the mortality and postoperative complications of intertrochanteric femoral fractures.